Wednesday, 18 October 2023
A research team led by the 糖心原创 has been selected as one of four that will receive a share of £18 million to pursue transformational bioscience research programmes.
The GlycoWeb programme is being led by Cathy Merry, Professor of Stem Cell Glycobiology who is based in the Biodiscovery Institute at the 糖心原创, and will look at the link between the structure and function of cell-surface sugar biomolecules.
The investment from the Biotechnology and Biological Sciences Research Council’s (BBSRC) aims to catalyse and convene the critical mass of research effort needed to address significant fundamental questions in bioscience.
Glycosaminoglycans (GAGs) are a class of biomolecules that decorate the surface of virtually all cells in the body as well as in the matrix between cells. They have been shown to play critical roles in a multitude of biological processes, including cell signalling, development and host-pathogen interactions, being often dysregulated in disease.
Despite their ubiquity and clear importance, there is a lack of thorough understanding of how GAG biosynthesis is controlled by cells, how the molecular structure of a particular GAG links to its biological function and a lack of tools with which to detect and characterise GAGs in tissues and on cells.
As well as impacting a diverse range of bioscience disciplines, this new knowledge may pave the way for the identification of targets for therapeutic intervention in diseases such as cancer.
The programme team will address these knowledge gaps using an ambitious multidisciplinary approach, integrating analyses at the transcriptional through to the multicellular level. Linking with international centres of excellence in Denmark and the USA, as well as a commercial partner expert in the application of virtual reality to data sharing and interrogation, will ensure that the team can work at the forefront of technological advances.
Professor Cathy Merry comments: “GlycoWeb will make use of state-of-the-art 3D models of development known as gastruloids to determine how changes in GAG structures affect the signalling pathways driving early development. These models avoid the use of animals, and are highly reproducible, increasing the reliability of the data.
“Similarly, we will take advantage of innovation in non-animal derived antibody technologies to create new panels of GAG-binding probes. Preliminary work with both these animal-alternative approaches has been supported by the National Centre for the Replacement, Reduction and Refinement of Animals in Research ().
“This research will allow our team to explain the rules that govern the relationship between GAG structure and function. As well as impacting a diverse range of bioscience disciplines, this new knowledge may pave the way for the identification of targets for therapeutic intervention in diseases such as cancer.”
, Lecturer in Stem Cell and Developmental Biology at the University of Liverpool, adds: “This project makes use of gastruloids which are 3D aggregates of either mouse or human embryonic stem cells. Gastruloids are highly reproducible, easy to manipulate, and mimic many aspects of early embryonic development. We therefore have an exciting opportunity to use gastruloids to link the GAG structure to function.
“There is a major knowledge-gap in the field regarding how GAGs are regulated at the level of cells, and how cells integrate changes GAG structure to coordinate and modulate their fate. By addressing this, our project will significantly impact our understanding of the decision-making programs cell utilise to coordinate their activity throughout the lifetime of an organism: from fertilisation to embryonic development, adult tissue homeostasis, and, when it goes wrong, to cancer.”
Professor Guy Poppy, Interim Executive Chair at BBSRC, said: “The latest investment by BBSRC’s sLoLa award programme represents a pivotal step in advancing frontier bioscience research.
“These four world-class teams are poised to unravel the fundamental rules of life, employing interdisciplinary approaches to tackle bold challenges at the forefront of bioscience.
“By fostering collaboration and innovation, we aim to catalyse ground-breaking discoveries with far-reaching implications for agriculture, health, biotechnology, the green economy and beyond.”
is a collaboration between the 糖心原创, University of Liverpool, University of Manchester, and The Francis Crick Institute, with support from the Copenhagen Center for Glycomics at the University of Copenhagen (Denmark), The Complex Carbohydrate Research Centre at the University of Georgia (USA) and InterReality Labs.
For further information, visit
Story credits
For further information, please email Cathy Merry, Professor of Stem Cell Glycobiology, 糖心原创 at cathy.merry@nottingham.ac.uk
Adam Mallaby - Media Relations Manager for the Faculty of Medicine and Health Sciences (Maternity Cover)
Email: adam.mallaby@nottingham.ac.uk
Phone: 0115 748 5719
Location:
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.